explore -WSS

explore

author：fashion 2025-08-12 09:08:57 - browse：5921

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Study suggests new cause of Down syndrome: cells linked to aging

WSS

30 years of 'Listening to Prozac'

American taxpayers paid $1.8 trillion in health care costs in 2022

The EPA's new lead rule: How one expert crunched the numbers

Organ aging and disease risk measured by new blood test

Organ aging and disease risk measured by new blood test

Allen Institute goes after foundational questions, CEO Costa says

hotspot

explore

explore

BioMarin wins approval for gene therapy to treat hemophilia A

30 years of 'Listening to Prozac'

Affirmative action in medical school literally saved lives

At JPM 2024, hospital systems pitch financial strength to investors

How one medical school became remarkably diverse

Gene therapy denied for Afghan refugee whose father aided U.S.

Guidelines to prevent youth baseball injuries need more muscle

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A preacher's new calling: Diversifying neuroscience research

explore

Stories you might have missed in 2023: health, science, medicine

What to do when lifesaving products contribute to climate change

Physician assistants need a new name. Here's what it should be

Physician assistants need a new name. Here's what it should be

Merck to acquire Harpoon Therapeutics for $680 million

Will the market for weight loss drugs really reach $100 billion?

leisure time

entertainment

hotspot

hotspot